started · updated
Amyris to acquire sweet protein innovator Oobli
Amyris, Inc., a biomanufacturing company based in Emeryville, California, has announced the acquisition of Oobli Inc., a specialist in fermentation-based sweet proteins. The move aims to combine Amyris’ manufacturing depth and strain engineering with Oobli’s expertise in producing proteins that can replace sugar in food and beverage products.
Oobli has spent a decade developing a fermentation process to replicate sweet proteins found in rare equatorial fruits and berries. These proteins, such as brazzein, monellin, and thaumatin, are hundreds to thousands of times sweeter than sugar and are metabolized by the body as protein, which may help prevent blood sugar spikes. The ingredients hold FDA Generally Recognized as Safe (GRAS) status.
The acquisition follows Amyris’ recent expansion of its fermentation facility in Barra Bonita, Brazil. The combined company intends to apply these technologies across various sectors, including food and beverage, personal care, flavors, fragrances, and agriculture.
Entities
Amyris, Inc. · Barra Bonita · FDA · Kathy Fortmann · Oobli Inc.